HSA in block letters with rolled up currency on top In 2019, the IRS tweaked coverage to allow certain drugs to treat chronic conditions to be covered pre-deductible. (Photo: Shutterstock)

A recent regulatory change expanding the number of medications included for pre-deductible coverage did not result in significantly increased insurance premiums, a new study has found.

The report from the Employee Research Benefits Institute (EBRI) looked at a regulation change from 2019 that expanded the list of pre-deductible drugs to include several that address chronic diseases. The change by the IRS allowed Health Savings Account (HSA)-eligible health plans to provide pre-deductible coverage to 14 medications and services that treat chronic illnesses.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Employee-Paid
Employer-Paid
Defined Contribution